Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Kernan, Walter N., Viscoli, Catherine M., Furie, Karen L., Young, Lawrence H., Inzucchi, Silvio E., Gorman, Mark, Guarino, Peter D., Lovejoy, Anne M. +19 more·2016·New England Journal of Medicine
DOI 10.1056/nejmoa1506930

Cited by (1,110)

Items 1,001–1,100 of 1,110

  1. Precision Medicine for Diabetes and Dyslipidemia
    Ethan Alexander, Elizabeth Cristiano, John M. Miles · 2022 · Springer eBooks
  2. A súlyfelesleg és annak csökkentése kardiovaszkuláris szempontból
    László Bajnok · 2021 · Cardiologia Hungarica
  3. First Records Of Chlamydatus Saltitans (Fallén, 1807) And Tupiocoris Rhododendri (Dolling, 1972) (Heteroptera, Miridae) And Notes On Other Rare And Alien True Bugs In Switzerland
    David Frey, Andrea Zanetta, Marco Moretti · 2016 · INFM-OAR (INFN Catania)
  4. Herz und Diabetes
    Dirk Müller‐Wieland, Nikolaus Marx · 2022 · Springer Reference Medizin
  5. Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus
    Bernd M. Balletshofer, Dittmar Böckler, die DGG, Holger Diener, Jörg Heckenkamp, Wulf D. Ito, Marcus Katoh, Holger Lawall, die DGA, Nasser M. Malyar et al. · 2022 · Die Diabetologie
  6. Part Six: Antidiabetic Medication Benefits Beyond Glucose Lowering in Older People
    Elizabeth K. Pogge, Nicole K. Early · 2022 · The Senior Care Pharmacist
  7. Metabolic Profile as a Predictor of Ischaemic Stroke: The Experience of a Rural Hospital in Nigeria
    Orebowale A. Olugbemide, Idowu A. Bankole, Adewumi Olabimpe Alabi, Mercy Ofunami Dic‐Ijiewere, Aihanuwa Eregie, Olufemi Adetola Fasanmade · 2023 · African Journal of Health Sciences
  8. Current management of diabetes patients with COVID-19
    Arup Kumar Misra, Gaurav Manikrao Rangari, C Madhavrao, Sushil Kumar Sharma · 2023 · Expert Review of Endocrinology & Metabolism · Retracted
  9. Tailoring the Treatment of Type 2 Diabetes Mellitus to the Individual
    Patricia R. Peter, Silvio E. Inzucchi · 2023 · Contemporary cardiology
  10. Diabetes and Stroke: The Role of Glucose Regulation
    Forrest J. Lowe, Wuwei Feng, Carlos Gerardo Cantú-Brito · 2023 · Springer eBooks
  11. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
    Chin‐Hsiao Tseng · 2023 · Frontiers in Endocrinology
  12. Effect of pioglitazone on proteinuria and cardiovascular events in patients with diabetic nephropathy
    Seyyedeh Mina Hejazian, Sepideh Zununi Vahed, Nooshin Khadem Haghighi, Bahram Niknafs, Farahnoosh Farnood · 2023 · Journal of Renal Injury Prevention
  13. Contribution of Doppler Ultrasound of the Supra-Aortic Trunks in the Etiological Evaluation of Ischemic Strokes at the Douala General Hospital
    Felicité Kamdem, Felicité Kamdem, Farol Maka Kamdem et al. · 2023 · Journal for Vascular Ultrasound
  14. How to mitigate residual risk? Risk factor management, a holistic approach to cardiovascular risk and treatment goals other than LDL (non-HDL-c, Lp(a), TG, apoB)
    Juan Patricio Nogueira, Hernando Vargas‐Uricoechea, Solón Navarrete · 2023 · Revista Colombiana de Cardiología
  15. Cost-utility analysis of low-dose pioglitazone in a population with prediabetes and a history of stroke and TIA
    Fei Yuan, John David Spence, Jean‐Éric Tarride · 2023 · medRxiv
  16. Tratamiento farmacológico actual y futuro de la esteatosis hepática
    Núria Alonso, María Teresa Julián · 2023 · Diabetes práctica
  17. Pancreatic Gland Therapies
    Akuffo Quarde · 2023
  18. Incidence and Trends in Ischemic Stroke and Mortality in Patients with and Without Type 2 Diabetes in Taiwan 2000-2018
    Fu‐Shun Yen, James Cheng‐Chung Wei, Tzu-Ju Hsu · 2023 · medRxiv
  19. Herz und Diabetes
    Dirk Müller‐Wieland, Nikolaus Marx · 2023 · Springer Reference Medizin
  20. How to Use Type 2 Diabetes Treatments in Clinical Practice
    Thomas Karagiannis, Aris Liakos, Απόστολος Τσάπας · 2024
  21. Ischaemic Heart Disease in Diabetes
    Michael Lehrke, Nikolaus Marx · 2024 · Wiley eBooks
  22. Role of newer anti-diabetes drugs in prediabetes: A systematic review
    Awadhesh Kumar Singh, Ritu Singh · 2024 · Elsevier eBooks
  23. Research Progress of Triglyceride-Glucose (TyG) Index in Atherosclerotic Cerebral Infarction
    ·阿布力克木 尼格热木 · 2024 · Advances in Clinical Medicine
  24. Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) bei Menschen mit Diabetes mellitus
    Bernd M. Balletshofer, Dittmar Böckler, Holger Diener, Jörg Heckenkamp, Wulf D. Ito, Marcus Katoh, Holger Lawall, Nasser M. Malyar, Hui Jing Qiu, Peter Reimer et al. · 2024 · Die Diabetologie
  25. Heart failure in diabetes: Current clinical management
    Evelyn Santiago‐Vacas · 2024 · Elsevier eBooks
  26. Nonalcoholic fatty liver disease: What comes before and what are the consequences?
    Fernando Bril · 2024 · Elsevier eBooks
  27. Symptomatic Extracranial Large Artery Disease
    Mahmoud Reza Azarpazhooh, Chrysi Bogiatzi, John David Spence · 2024 · Springer eBooks
  28. Tailored Approach to Secondary Prevention After Stroke
    Fred Stephen Sarfo, Bruce I Ovbiagele · 2024 · Springer eBooks
  29. The association between triglyceride-glucose index and its combination with obesity indicators and stroke: CHARLS 2011-2020
    Weicai Liang, Haichun Ouyang · 2024 · Research Square
  30. Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
    Don P. Wilson, Luke Hamilton, Kevin Carl Maki · 2024 · Contemporary cardiology
  31. Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes
    Silvio E. Inzucchi, Andrew E. Arai · 2024 · Journal of the American College of Cardiology
  32. Geriatric Pharmacotherapy Case Series: Medications for Diabetes—A Focus on Secondary Stroke Prevention
    Sabrina Warren, Shayla McKee, Erin Yakiwchuk · 2024 · The Senior Care Pharmacist
  33. Secondary stroke prevention
    Lintu Ramchandran, Afshin A. Divani, Archana Hinduja, Rahul H. Damani · 2024 · Elsevier eBooks
  34. Sequelae of Prediabetes: Progression to Type 2 Diabetes and Development of Premature Microvascular and Macrovascular Complications
    2021 · American Diabetes Association eBooks
  35. Curalin supplement as add-on therapy for type 2 diabetes Mellitus
    Itamar Raz, Roni Weinberg Sibony, Saar Dor, Aliza Rozenberg, Ilan Yanuv, Ofer Yigdal, Ron Elul, Omri Segev · 2024 · Diabetes Research and Clinical Practice
  36. Diabetes mellitus and stroke: Diagnosis, nursing interdisciplinary management, and medical secretary documentation practices
    Naif Lahiq Mohsen Alotaiby, Awadh Awaadh Saad Alotaiby, Tariq Abdulaziz Al-Falih, Shams Mohammed Alqahtani, Ola Yousef Fadan, Ali Khalil Hassan Khader · 2017 · International Journal of Health Sciences
  37. Pharmacological Interventions of Metabolic Syndrome
    Anita A. Mehta, Jayesh Beladiya, Tejal Gandhi · 2024 · Advances in biochemistry in health and disease
  38. 10.1016/j.ymed.2016.08.050
    2000 · Time to knit
  39. Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Fernando Bril, Gabriela Alicia Berg, Magalí Barchuk, Juan Patricio Nogueira · 2025 · Journal of Lipid and Atherosclerosis
  40. Management
    Iram Hussain, Janice MacLeod, Fredrick Dunn, Perry E. Bickel, Marconi Abreu, Nicole McNulty, Ildiko Lingvay, Asra Kermani, Marconi Abreu · 2020 · American Diabetes Association eBooks
  41. Qini Curves for Potential Impact Assessment of Risk Predictive Models Informing Intervention Policies
    Pierpaolo Palumbo · 2025 · Value in Health
  42. Cardiodiabetology: Evolution or Revolution?
    I. Z. Bondarenko, V. Y. Kalashnikov · 2025 · Diabetes Mellitus
  43. 2. Medical Strategy for Secondary Stroke Prevention
    Kazuo Kitagawa · 2024 · Nihon Naika Gakkai Zasshi
  44. Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus
    Bernd M. Balletshofer, Dittmar Böckler, Holger Diener, Jörg Heckenkamp, Wulf D. Ito, Marcus Katoh, Holger Lawall, Nasser M. Malyar, Hui Jing Qiu, Peter Reimer et al. · 2025 · Die Diabetologie
  45. Ischemic Stroke, Type 2 Diabetes, Glucose-Lowering Drugs, and Cardiovascular Events
    Laurent Fauchier, Lisa Lochon, Mickael Guglieri · 2025 · Mayo Clinic Proceedings
  46. Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP ‐4 inhibitors: A multicentre, phase 4 randomized controlled trial
    Yun Kyung Cho, Jae‐Hyoung Cho, Sangmo Hong et al. · 2025 · Diabetes Obesity and Metabolism
  47. Impact of Fructose‐Enhanced Solid and Soft Drink Diets on Metabolism, Physiology, and Gut Microbiome in Pregnant Rats
    Xiaoyuan Han, Linda M. Dairiki Shortliffe, Neeraja Kambham · 2025 · BioMed Research International
  48. Additive cardioprotection by dapagliflozin and pioglitazone co-therapy in streptozotocin-induced diabetic rats
    Eva Kralova, Aneta Čináková, Ján Klimas, Peter Křenek · 2025 · Journal of Pharmacy and Pharmacology
  49. Reducing the risk of developing diabetes
    Henri Honka, Elina Pimiä · 2025 · Elsevier eBooks
  50. Pharmakotherapie des PCOS aus internistischer Sicht
    Young Hee Lee-Barkey, Bernd Stratmann, Jasmin Mona Klose, Susanne Tan · 2025 · Die Gynäkologie
  51. Genotype‐guided dual antiplatelet therapy in minor stroke or transient ischemic attack with metabolic syndrome: A post hoc analysis of CHANCE ‐2
    Zhiyuan Feng, F Zhang, Aoming Jin et al. · 2025 · Diabetes Obesity and Metabolism
  52. Thiazolidinediones
    Kam L. Capoccia, Peggy Soule Odegard · 2025 · American Diabetes Association eBooks
  53. Metabolic dysfunction-associated steatotic liver disease: Role in the development of comorbid conditions and therapeutic management
    Tatiana Yu. Demidova, Victoria V. Titova, A. N. Levitskaya, M. A. Gyozalyan · 2025 · Meditsinskiy sovet = Medical Council
  54. Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study
    Kyuho Kim, Seung‐Hyun Ko, Jae‐Seung Yun, Kwan Woo Lee, Eun‐Sook Kim, In‐Kyung Jeong, Jae Hyeon Kim, Sang Yong Kim, Kyu Chang Won, Mi-Kyung Kim et al. · 2025 · Scientific Reports
  55. Heart and Diabetes
    Dirk Müller‐Wieland, Nikolaus Marx · 2024 · Springer eBooks
  56. Semaglutide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits
    Naseem Eisa, Omar Barood · 2025 · Endocrine Practice
  57. Additional file 1 of Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
    Joonsang Yoo, Jimin Jeon, Minyoul Baik, Jinkwon Kim · 2024 · Figshare
  58. Additional file 1 of Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
    Chan, Cheng-Wei, Yu, Chu-Leng, Lin, Jiunn-Cherng, Yu‐Cheng Hsieh, Lin, Che-Chen, Hung, Chen-Ying, Li, Cheng-Hung, Liao, Ying-Chieh, Lo, Chu-Pin, Huang, Jin-Long et al. · 2018 · Figshare
  59. Additional file 1 of Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke
    Matz, Karl, Tuomilehto, Jaakko, Yvonne Teuschl, Alexandra Dachenhausen, Brainin, Michael · 2020 · Figshare
  60. Additional file 1 of Dual-trajectory of TyG levels and lifestyle scores and their associations with ischemic stroke in a non-diabetic population: a cohort study
    Zhou, Hui, Ding, Xiong, Lan, Yulong · 2024 · Figshare
  61. Additional file 1 of Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
    Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Murakami, Takaaki, Tanaka, Daisuke, Fujita, Yoshihito, Norio Harada, Akihiro Hamasaki, Inagaki, Nobuya · 2024 · Figshare
  62. Additional file 1 of Association of the triglyceride–glucose index with coronary artery disease complexity in patients with acute coronary syndrome
    Xiong, Shiqiang, Chen, Qiang, Yu Long, Su, Hong, Yan Luo, Liu, Hanxiong, Yingzhong Chen, Qiao Feng, Xiufen Peng, Maoling Jiang et al. · 2024 · Figshare
  63. Additional file 1 of Association between the insulin resistance and all-cause mortality in patients with moderate and severe aortic stenosis: a retrospective cohort study
    Huang, Rihua, Xinghao Xu, Xu, Chaoguang, Zhang, Shaozhao, Xiong, Zhenyu, Menghui Liu, Huang, Yiquan, Wen, Han, Yue Guo, Liao, Xinxue et al. · 2023 · Figshare
  64. Additional file 1 of Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
    Xiaoteng Ma, Dong, Lisha, Shao, Qiaoyu, Cheng, Yujing, Sai Lv, Sun, Yan, Hua Shen, Wang, Zhijian, Zhou, Yujie, Liu, Xiaoli · 2020 · Figshare
  65. Additional file 1 of Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients
    Lu, Zhengzhao, Yunyun Xiong, Xueyan Feng, Kaixuan Yang, Gu, Hongqiu, Zhao, Xingquan, Meng, Xia, Yongjun Wang · 2023 · Figshare
  66. Additional file 1 of Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia
    Elena Fortin, Magnus Lundin, Mellbin, Linda, Anna Norhammar, Per Näsman, Stina Smetana, Peder Sörensson, Ferrannini, Ele, Rydén, Lars, Giulia Ferrannini · 2023 · Figshare
  67. Additional file 1 of Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
    Junghee Ha, Choi, Dong-Woo, Keun You Kim, 김진흠, Kim, Eosu · 2021 · Figshare
  68. Additional file 1 of Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial
    Tanaka, Atsushi, Imai, Takumi, Michio Shimabukuro, Taguchi, Isao, Akira Sezai, Toyoda, Shigeru, Watada, Hirotaka, Junya Ako, Node, Koichi · 2022 · Figshare
  69. Additional file 1 of Impaired glucose metabolism and the risk of vascular events and mortality after ischemic stroke: A systematic review and meta-analysis
    Nurcennet Kaynak, Valentin Kennel, Torsten Rackoll, Schulze, Daniel, Matthias Endres, Alexander Nave · 2024 · Figshare
  70. Additional file 2 of Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
    Ma, Xiaoteng, Dong, Lisha, Shao, Qiaoyu, Cheng, Yujing, Sai Lv, Sun, Yan, Hua Shen, Wang, Zhijian, Zhou, Yujie, Liu, Xiaoli · 2020 · Figshare
  71. Comparative study on the effect of sitagliptin, pioglitazone and dapagliflozine on myocardial infarction induced experimentally in diabetic rats
    Sherif M.A. Mansour, Ali A.A. Attia, Ahmed M.M. Elsherbiney · 2025 · Al-Azhar Assiut Medical Journal
  72. Positionspapier der DDG, DGA, DGG und DeGiR zur Diagnostik und Behandlung der pAVK bei Diabetes mellitus
    Kilian Rittig, Farzin Adili, Markus Zähringer, Nasser M. Malyar, Ulrich Rother, Bernd M. Balletshofer, Hui Jing Qiu, Peter Reimer, Holger Lawall · 2025 · Diabetologie und Stoffwechsel
  73. Decoding Diabetes Treatments
    Lauren Cline, Erica Wilson · 2026 · Physician Assistant Clinics
  74. Positionspapier der DDG, DGA, DGG und DeGiR zur Diagnostik und Behandlung der pAVK bei Diabetes mellitus
    Kilian Rittig, Farzin Adili, Markus Zähringer, Nasser M. Malyar, Ulrich Rother, Bernd M. Balletshofer, Hui Jing Qiu, Peter Reimer, Holger Lawall, Deutsche Diabetes Gesellschaft (DDG) et al. · 2026 · Die Diabetologie
  75. QUICKI is a Useful Biomarker in Predicting Clinical Outcomes Among Ischemic Stroke Patients Without Type 2 Diabetes Mellitus
    Dong Liu, Qian Jia, Hongyi Yan · 2026 · Neurology India
  76. Prediabetes, Diabetes and Peripheral Arterial Disease
    Gerit-Holger Schernthaner, Clemens Höbaus · 2026 · Springer eBooks
  77. Effect of Metformin in Diabetic Patients After Treatment of Intracranial Aneurysm: A Nationwide Cohort Study
    Minyoul Baik, Jimin Jeon, Tae‐Jin Song, Joonsang Yoo, Jinkwon Kim · 2026 · Journal of Korean Medical Science
  78. Antihyperglycemic Medications With Proven Cardiovascular Safety
    Jennifer B. Green · 2026 · Elsevier eBooks
  79. Insulin resistance and ischemic stroke
    Н. В. Пизова, A. V. Pizov · 2026 · Russian neurological Journal
  80. Challenges in personalized evidence-based medicine, applications in type 2 diabetes
    Guillaume Grenet · 2019
  81. Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )
    John Armato, Ralph A. DeFronzo, Muhammad A Abdul‐Ghani, Ron Ruby · 2026 · Diabetes Obesity and Metabolism
  82. Emirates Diabetes and Endocrine Society Consensus for the Management of Type 2 Diabetes Mellitus (2026 Update)
    Fatheya Alawadi, Elamin Abdelgadir, Ahmed Abdul Karim Hassoun, Salah Abusnana, Bachar O. Afandi, Khaled M. Aldahmani, Juma Alkaabi, Alaaeldin M. Bashier, Faten Bayado, Buthaina Abdulla Bin Belaila et al. · 2026 · Dubai Diabetes and Endocrinology Journal
  83. Cardiovascular outcomes with thiazolidinediones and sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus undergoing peripheral artery revascularization
    Ji Woong Roh, Jimin Jeon, Joonsang Yoo, Minyoul Baik, Seok‐Jae Heo, D K Cho, Jinkwon Kim · 2026 · Diabetes Research and Clinical Practice
  84. Association of Antidiabetic Medication Classes With Survival Outcomes in Pulmonary Hypertension Patients With Diabetes
    Aaron W. Trammell, Divya Verma, ALYSSA CRUSE, Xiangqin Cui, Matthew Ryan Smith, C. Michael Hart · 2026 · Pulmonary Circulation
  85. Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial
    Longyan Lu, Bing You Yang, Yao Wang, Chaoli Zhu, Zechao Liu, Fangze Li, Shumin Yang, Yanfang Liu, Ying Yang, Xiaoyan Liu et al. · 2026 · Stroke
  86. DTMB attenuates hepatic inflammation and lipid dysregulation via PPAR-γ modulation in diet-induced steatohepatitis
    Jae Won Lee, Eun-Ji Oh, Sungji Cho, Jeong-Hwa Kang, Seung-Hee Gwak, Won‐Sik Shin, Suhyun Yoon, Yong‐Hyun Han, Jongshin Kim, Kyong‐Tai Kim · 2026 · European Journal of Pharmacology
  87. Cellular senescence in ischemic stroke: Cell-type specificity, temporal dynamics, and response to therapeutic interventions
    Xiaolong Liu, Yu Guo, Aurel Popa‐Wagner, Ingo Lämmermann, Johannes Grillari, Dirk Matthias Hermann · 2026 · Ageing Research Reviews
  88. Semi-automated, evidence-based workflow for selection of reference chemicals for the validation of NAMs: a case study with the adipogenesis assay
    Hana Carolina Moreira Farnezi, Sander B.I. Lentz, Juliette Legler, Jorke Harmen Kamstra · 2026 · NAM journal.
  89. Association Between Pioglitazone Use and Risk of Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Stable Coronary Artery Disease: A Retrospective Analysis From the North Florida Region
    Hussein A Noureldine, Andrew Abraham, Sanaullah Mojaddedi, Qusai Alqudah, Ajaypal S. Gill, Ann T. Tong · 2026 · CardioMetabolic Syndrome Journal
  90. Insulin Action in the Brain
    Heather A. Ferris · 2026 · Elsevier eBooks
  91. A data-driven multimodal diagnostic framework for quality evaluation of artificial calculus bovis based on HEMT biosensors and systematic quality data engineering
    Kaiyi Wang, Fangyu Zhang, Yufeng Guo, Huimin Feng, Xinhai Chen, Jing Wang, Yifei Wang, Yao Lu, Zhaohua Zhang, Jun Jia et al. · 2026 · Chemical Engineering Journal
  92. Heart-liver co-management: epidemiology, mechanisms, and novel therapeutic approaches for metabolic dysfunction-associated steatotic liver disease and coronary artery disease
    Sirui Zhu, Fangkun Yang, Haoxuan Lu, Jun Jiang, He WQ · 2026 · Frontiers in Cardiovascular Medicine
  93. Effects of Long-Term Lobeglitazone Treatment on Renal Function and Albuminuria in Korean Patients with Type 2 Diabetes Mellitus: A Multicenter Retrospective Observational Study (LUCKY)
    Hee‐Sung Kim, Chang Hee Jung, Jung-hyun Noh · 2026 · Diabetes Therapy
  94. Position Paper of the German Diabetes Association, German Society of Angiology and Vascular Medicine, German Society for Vascular Surgery and Vascular Medicine and German Society for Interventional Radiology and Minimally Invasive Therapy on the Diagnosis and Treatment of Peripheral Arterial Occlusive Disease in Diabetes Mellitus
    Kilian Rittig, Farzin Adili, Markus Zähringer, Nasser M. Malyar, Ulrich Rother, Bernd M. Balletshofer, Hui Jing Qiu, Peter Reimer, Holger Lawall · 2026 · Experimental and Clinical Endocrinology & Diabetes
  95. Oral Hypoglycemic Therapy in Metabolic Dysfunction-Associated Fatty Liver Disease
    O. O. Karshina, Ibragim S. Sabirov, E. A. Mohammad · 2026 · Экспериментальная и клиническая гастроэнтерология
  96. Cardiometabolic Syndrome Part 2: Pharmacological Management, Public Health Strategies, and Future Direction
    Soo Kyung Lim, You‐Cheol Hwang, Jang Won Son, Seung‐Hwan Lee, Chang Hee Jung, Hyun‐Jin Kim, Hyunjung Lim, Seong‐Mi Park, Jang‐Young Kim, Jong‐Chan Youn et al. · 2026 · CardioMetabolic Syndrome Journal
  97. Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes
    Tae Hyeon Kim, Yerin Hwang, Selin Woo, Kyeongmin Lee, Yejun Son, Seoyoung Park, Hyunjee Kim, Ju‐Young Shin, YongHyun Cho, Dahye Shin et al. · 2026 · Medicine
  98. Cardiometabolic drugs after stroke: time to embrace SGLT2 inhibitors and incretin-based therapies?
    Håkon Ihle‐Hansen, Hege Ihle-Hansen, Rolf Ankerlund Blauenfeldt, Jesse Dawson, Søren Z. Diederichsen, Guri Hagberg · 2026 · Frontiers in Stroke
  99. Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception
    Nizameddin Koca, Seyit Uyar, Yasin Şahintürk, Hamit Yıldız, Stefano Del Prato, Ralph Anthony DeFronzo · 2026 · Cardiovascular Diabetology
  100. Distúrbios do metabolismo dos hidratos de carbono na síndrome dos ovários policísticos
    Cristiano Roberto Grimaldi Barcellos · 2019 · Femina